1. Home
  2. ASST vs CTKB Comparison

ASST vs CTKB Comparison

Compare ASST & CTKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Asset Entities Inc. Class B

ASST

Asset Entities Inc. Class B

HOLD

Current Price

$16.45

Market Cap

685.1M

Sector

Technology

ML Signal

HOLD

Logo Cytek Biosciences Inc.

CTKB

Cytek Biosciences Inc.

HOLD

Current Price

$4.66

Market Cap

595.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ASST
CTKB
Founded
2020
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
685.1M
595.2M
IPO Year
2022
2021

Fundamental Metrics

Financial Performance
Metric
ASST
CTKB
Price
$16.45
$4.66
Analyst Decision
Strong Buy
Hold
Analyst Count
4
4
Target Price
$23.50
$5.63
AVG Volume (30 Days)
3.6M
521.3K
Earning Date
05-14-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
82.56
N/A
EPS
N/A
N/A
Revenue
$633,489.00
$193,015,000.00
Revenue This Year
$294.91
$5.42
Revenue Next Year
$12.16
$7.03
P/E Ratio
N/A
N/A
Revenue Growth
128.67
17.67
52 Week Low
$0.49
$2.37
52 Week High
$17.89
$6.18

Technical Indicators

Market Signals
Indicator
ASST
CTKB
Relative Strength Index (RSI) 67.86 55.57
Support Level $0.74 $4.56
Resistance Level $17.89 $4.80
Average True Range (ATR) 1.16 0.19
MACD -0.01 0.00
Stochastic Oscillator 74.19 87.50

Price Performance

Historical Comparison
ASST
CTKB

About ASST Asset Entities Inc. Class B

Strive Inc is engaged in providing investment advisory, wealth management, and consulting services through its subsidiary. Its objectives is to (i) accumulate Bitcoin; (ii) increase Bitcoin-per-share; and (iii) outperform Bitcoin over the long run by deploying both beta Bitcoin treasury accumulation strategies and alpha investment strategies with the goal of beating Bitcoin's investment performance as the hurdle rate.

About CTKB Cytek Biosciences Inc.

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of research and clinical tools with its novel technical approach of leveraging the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its patented FSP technology optimizes sensitivity and accuracy through its optical and electronic designs that utilize an inventive method of light detection and distribution to a specifically selected number and type of detectors. Its FSP cell analyzers, the Cytek Aurora, Northern Lights, and Cytek Aurora Evo systems, deliver high-resolution, high-content and high-sensitivity cell analysis and address the inherent limitations of other technologies.

Share on Social Networks: